JON S. SAXE - Corporate Board Profile

DURECT CORP

Filing Date	Source Excerpt
2006-04-27	Jon S. Saxe has served as a director since September 2003. Mr. Saxe is currently a director of a number of biotechnology and pharmaceutical companies including PDL Biopharma (formerly Protein Design Labs Inc.), First Horizon Pharmaceuticals, SciClone, Questcor, InSite Vision, and several private companies.
2007-04-30	Jon S. Saxe has served as a director since September 2003. Mr. Saxe is currently a director of a number of biotechnology and pharmaceutical companies including PDL Biopharma (formerly Protein Design Labs, Inc.), Sciele, SciClone, InSite Vision, and several private companies.
2008-04-29	Jon S. Saxe has served as a director since September 2003. Mr. Saxe is currently a director of a number of biotechnology and pharmaceutical companies including PDL Biopharma (formerly Protein Design Labs, Inc.), Sciele, SciClone, InSite Vision, and several private companies.
2009-04-29	Jon S. Saxe has served as a director since September 2003. Mr. Saxe is currently a director of a number of biotechnology and pharmaceutical companies including SciClone, Entelos, Inc., and several private companies.
2010-04-29	Jon S. Saxe has served as a director since September 2003. ... (1) Member of the Compensation Committee ... (2) Member of the Audit Committee ... Director Compensation for Fiscal 2009: Jon S. Saxe Fees Earned or Paid in Cash $57,000, Option Awards $32,324, Total $89,324.
2011-04-28	Jon S. Saxe has served as a director since September 2003. ... The Audit Committee was composed of the following directors: Simon X. Benito, David R. Hoffmann and Jon S. Saxe. ... The Compensation Committee was composed of Michael D. Casey, David R. Hoffmann, Armand P. Neukermans and Jon S. Saxe. ... Director Compensation for Fiscal 2010: Jon S. Saxe $106,308.
2012-04-26	Jon S. Saxe has served as a director since September 2003. ... The Audit Committee was composed of the following directors: Simon X. Benito, David R. Hoffmann and Jon S. Saxe. ... The Compensation Committee was composed of Michael D. Casey, David R. Hoffmann, Armand P. Neukermans and Jon S. Saxe. ... Director Compensation for Fiscal 2011: Jon S. Saxe total $112,063.
2013-04-29	Jon S. Saxe has served as a director since September 2003. ... Mr. Saxe’s legal and business expertise and pharmaceutical industry experience relates to executive management, licensing, corporate development, intellectual property and legal matters and his board experience including as chairperson of audit and compensation committees are among the qualifications he brings to the Board and his service as a Director of the Company.
2014-04-23	Jon S. Saxe has served as a director since September 2003. Mr. Saxe is currently a director of a number of biotechnology and pharmaceutical companies including SciClone, VistaGen and several private companies. In addition, during the last five years, Mr. Saxe served on the Board of Directors of the following public companies: Sciele Pharma, Inc., InSite Vision and PDL Biopharma. From January 1995 to May 1999, Mr. Saxe was President of Protein Design Labs. During 1999, he was an Executive-in-Residence at Institutional Venture Partners, a venture capital firm. Mr. Saxe was President of Saxe Associates, a biotechnology and pharmaceutical consulting firm, from May 1993 to December 1994. He served as President, Chief Executive Officer and as a director of Synergen, Inc., a biopharmaceutical company acquired by Amgen from October 1989 to April 1993. From August 1984 through September 1989, Mr. Saxe was Vice President, Licensing and Corporate Development at Hoffmann-LaRoche and also head of the patent law department and Associate General Counsel at the company from September 1978 through September 1989. Mr. Saxe received his B.S. in Chemical Engineering from Carnegie-Mellon University, a J.D. from George Washington University School of Law and an LL.M. from New York University School of Law. Mr. Saxe’s legal and business expertise and pharmaceutical industry experience relates to executive management, licensing, corporate development, intellectual property and legal matters and his board experience including as chairperson of audit and compensation committees are among the qualifications he brings to the Board and his service as a Director of the Company.
2015-04-22	Jon S. Saxe has served as a director since September 2003. ... Mr. Saxe's legal and business expertise and pharmaceutical industry experience as relates to executive management, licensing, corporate development, intellectual property and legal matters and his board experience including as chairperson of audit and compensation committees are among the qualifications he brings to the Board and his service as a Director of the Company.
2016-04-28	Jon S. Saxe has served as a director since September 2003. Mr. Saxe is currently a director of a number of biotechnology and pharmaceutical companies including SciClone, VistaGen and several private companies.
2017-04-27	Jon S. Saxe has served as a director since September 2003. ... The Audit Committee was composed of the following directors: Simon X. Benito, David R. Hoffmann and Jon S. Saxe. ... The Compensation Committee was composed of Simon X. Benito, David R. Hoffmann, Armand P. Neukermans and Jon S. Saxe.
2018-04-27	Jon S. Saxe has served as a director since September 2003. ... Mr. Saxe’s legal and business expertise and pharmaceutical industry experience as relates to executive management, licensing, corporate development, intellectual property and legal matters and his board experience including as chairperson of audit and compensation committees are among the qualifications he brings to the Board and his service as a Director of the Company.
2019-04-26	Jon S. Saxe (1)(2) 82 Director (1) Member of the Compensation Committee (2) Member of the Audit Committee Director Compensation for Fiscal 2018 Jon S. Saxe Fees Earned or Paid in Cash ($) 53,567 Option Awards ($) 90,244 Total ($) 143,811
2020-04-27	Jon S. Saxe (1)(2) 83 Director ... (1) Member of the Compensation Committee (2) Member of the Audit Committee (3) Member of the Nominating and Corporate Governance Committee ... Director Compensation for Fiscal 2019 Jon S. Saxe 57,500 Fees Earned or Paid in Cash ($) 112,658 Option Awards ($) — All Other Compensation ($) 170,158 Total ($)
2021-04-23	Jon S. Saxe has served as a director since September 2003. ... Mr. Saxe’s legal and business expertise and pharmaceutical industry experience relating to executive management, licensing, corporate development, intellectual property and legal matters and his board experience including as chairperson of audit and compensation committees are among the qualifications he brings to the Board and his service as a Director of the Company.